Cencora (WBO:ABC) Tariff Resilience Score: 8/10 (As of Jun. 29, 2026)


WBO:ABC Cencora Inc WBO:ABC
69 GF Score
Price €254.30
GF Value €259.48
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Tariff Resilience Score?

Cencora WBO:ABC -0.27% 69 Tariff Resilience Score is 8 as of Jun. 29, 2026. GuruFocus rates WBO:ABC with a GF Score™ of 69/100 and a GF Value™ of €259.48 (Fairly Valued). The stock has 1 warning sign investors should review. Among 119 Medical Distribution companies, Cencora ranks better than 99.16% on this metric.

Cencora has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Cencora has Strong resilience with diversified global supply chain and significant domestic market. Historical adaptability to tariff changes and robust mitigation strategies.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Cencora might have Highly Resilient.

Cencora  (WBO:ABC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Cencora Tariff Resilience Score Related Terms

WBO:ABC vs CAH, MCK, HSIC: Tariff Resilience Score Comparison

For the Medical Distribution subindustry, Cencora's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cencora Tariff Resilience Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Cencora's Tariff Resilience Score falls into.


WBO:ABC
69GF Score
Cencora Inc WBO:ABC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Cencora (WBO:ABC) has a Tariff Resilience Score of 8 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Cencora ranks #1 out of 119 companies in the Medical Distribution industry, placing it in the top 0.8%.
Is Cencora's Tariff Resilience Score too high?
Cencora's current Tariff Resilience Score is 8. Based on the distribution chart, Cencora ranks #1 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cencora has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Tariff Resilience Score compare to CAH and MCK?
According to the Medical Distribution industry distribution chart, Cencora ranks #1 out of 119 companies for Tariff Resilience Score. This places Cencora in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Distribution company?
A good Tariff Resilience Score depends on the Medical Distribution industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Cencora's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €259.48, compared to a current price of €254.30 — trading 2% below its estimated fair value. The current Tariff Resilience Score is 8. Cencora's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Tariff Resilience Score is 8 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (WBO:ABC) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be undervalued. The current stock price of €254.30 is trading 2% below its estimated GF Value™ of €259.48. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for WBO:ABC:

  • Tariff Resilience Score: 8
  • GF Value™: €259.48 vs. price of €254.30 (2% below fair value)
  • GF Score™: 69/100 with 1 warning sign

No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
69GF Score

Get the complete analysis for WBO:ABC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€254.30
Price
€259.48
GF Value